Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.
Saved in:
| Title: | Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation. |
|---|---|
| Authors: | Augustine M; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Nene NR; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Statistical Science, University College London, London, UK., Fu H; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK., Pinder CL; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ligammari L; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Simpson AP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Sanz-Fernández I; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Thakkar K; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Qian D; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Fitzsimons E; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Simpson BS; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Vendramin R; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Castro A; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Niederer H; Cancer Research Horizons, The Francis Crick Institute, London, UK., Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Cancer Research UK City of London Centre, University College London, London, UK., McGranahan N; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Watkins C; Department of Computer Science, Royal Holloway, University of London, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Litchfield K; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. |
| Source: | Nature machine intelligence [Nat Mach Intell] 2026; Vol. 8 (5), pp. 670-689. Date of Electronic Publication: 2026 May 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101740243 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5839 (Electronic) Linking ISSN: 25225839 NLM ISO Abbreviation: Nat Mach Intell Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42206145 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Augustine+M%22">Augustine M</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Nene+NR%22">Nene NR</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Statistical Science, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Fu+H%22">Fu H</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Pinder+CL%22">Pinder CL</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Ligammari+L%22">Ligammari L</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+AP%22">Simpson AP</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Sanz-Fernández+I%22">Sanz-Fernández I</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Thakkar+K%22">Thakkar K</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Qian+D%22">Qian D</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Fitzsimons+E%22">Fitzsimons E</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+BS%22">Simpson BS</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Vendramin+R%22">Vendramin R</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Castro+A%22">Castro A</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Niederer+H%22">Niederer H</searchLink>; Cancer Research Horizons, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Turajlic+S%22">Turajlic S</searchLink>; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Quezada+SA%22">Quezada SA</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Cancer Research UK City of London Centre, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22McGranahan+N%22">McGranahan N</searchLink>; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Watkins+C%22">Watkins C</searchLink>; Department of Computer Science, Royal Holloway, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Litchfield+K%22">Litchfield K</searchLink>; Tumour Immunogenomics and Immunosurveillance (TIGI) Laboratory, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101740243%22">Nature machine intelligence</searchLink> [Nat Mach Intell] 2026; Vol. 8 (5), pp. 670-689. <i>Date of Electronic Publication: </i>2026 May 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101740243 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2522-5839 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225225839%22">25225839 </searchLink><i>NLM ISO Abbreviation: </i>Nat Mach Intell <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42206145 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42256-026-01201-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 670 Titles: – TitleFull: Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Augustine M – PersonEntity: Name: NameFull: Nene NR – PersonEntity: Name: NameFull: Fu H – PersonEntity: Name: NameFull: Pinder CL – PersonEntity: Name: NameFull: Ligammari L – PersonEntity: Name: NameFull: Simpson AP – PersonEntity: Name: NameFull: Sanz-Fernández I – PersonEntity: Name: NameFull: Thakkar K – PersonEntity: Name: NameFull: Qian D – PersonEntity: Name: NameFull: Fitzsimons E – PersonEntity: Name: NameFull: Simpson BS – PersonEntity: Name: NameFull: Vendramin R – PersonEntity: Name: NameFull: Castro A – PersonEntity: Name: NameFull: Niederer H – PersonEntity: Name: NameFull: Turajlic S – PersonEntity: Name: NameFull: Quezada SA – PersonEntity: Name: NameFull: McGranahan N – PersonEntity: Name: NameFull: Watkins C – PersonEntity: Name: NameFull: Swanton C – PersonEntity: Name: NameFull: Litchfield K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2522-5839 Numbering: – Type: volume Value: 8 – Type: issue Value: 5 Titles: – TitleFull: Nature machine intelligence Type: main |
| ResultId | 1 |